A recent study has unveiled a concerning development in hospital-acquired infections: a common superbug, Pseudomonas aeruginosa, has been found to digest medical-grade plastic, potentially exacerbating its threat in clinical settings.
Discovery of Plastic-Degrading Superbug
Researchers at Brunel University London identified a strain of P. aeruginosa, named PA-W23, capable of breaking down polycaprolactone (PCL)—a biodegradable polymer commonly used in medical devices such as sutures, stents, wound dressings, and implants. This bacterium utilizes an enzyme called Pap1 to degrade PCL, consuming it as its sole carbon source. In laboratory tests, Pap1 degraded nearly 80% of a PCL sample within just seven days.
Implications for Hospital Environments
The ability of P. aeruginosa to metabolize medical plastics has significant implications:
-
Enhanced Biofilm Formation: The degradation of PCL results in fragments that aid the bacterium in forming robust biofilms—protective layers that shield bacteria from antibiotics and the immune system, making infections more difficult to treat
-
Increased Virulence and Persistence: By feeding on medical plastics, the bacterium can survive longer on medical devices, potentially leading to more persistent and severe infections.
Broader Concerns
The discovery challenges the long-held belief that medical-grade plastics are resistant to microbial degradation. Furthermore, similar enzymes have been identified in other bacteria, suggesting that various medical plastics could be susceptible to degradation, raising concerns about the safety and longevity of medical devices.
Recommendations
In light of these findings, experts recommend:
-
Re-evaluating Medical Materials: Developing and utilizing plastics that are more resistant to microbial degradation in medical settings.
-
Enhanced Screening: Implementing screening protocols for plastic-degrading enzymes in pathogens, especially during unexplained or prolonged hospital outbreaks.
-
Further Research: Investigating the prevalence of plastic-degrading capabilities among other pathogens to better understand and mitigate potential risks.
This groundbreaking discovery underscores the need for heightened vigilance in infection control and the materials used in medical devices.
.jpg#){kind=link}